Compare DFSCW & MDAIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DFSCW | MDAIW |
|---|---|---|
| Founded | N/A | N/A |
| Country | Canada | United States |
| Employees | 30 | 78 |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | N/A |
| Metric | DFSCW | MDAIW |
|---|---|---|
| Price | $0.02 | $0.42 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | N/A | ★ 35.6K |
| Earning Date | N/A | 02-27-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $27,264,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 44.52 |
| 52 Week Low | N/A | $0.08 |
| 52 Week High | N/A | $0.90 |
| Indicator | DFSCW | MDAIW |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 44.44 |
| Support Level | N/A | $0.38 |
| Resistance Level | N/A | $0.48 |
| Average True Range (ATR) | 0.00 | 0.07 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 0.00 | 54.76 |
DEFSEC Technologies Inc is a canadian defence company. The company develops and commercializes next-generation tactical systems. The company offers breakthrough technology in lethal and non-lethal systems with broad application, including law enforcement and personal defence, modernized digitization of tactical forces for shared situational awareness and targeting, and counter-measures against threats such as drones, lasers, and electronic detection.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.